Latest filing published 20 Mar 2026 for Viemed Healthcare, INC., €258k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Michael Moore (chief executive) discloses dealings in Viemed Healthcare, Inc. to SEC (Form 4). Over a trading history stretching from 9 May 2021 to 18 March 2026, the count stands at 21 filings.
The open-market record consists of 2 sales worth €572k, with no purchase. Outside the open market, there are 2 share grants and 15 option exercises. Since January 2026: no purchases and 1 sale on the market.
The newest entry dates from 20 March 2026: an open-market sale of €258k, in Viemed Healthcare, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations